HSD17B2 and posterior cortical atrophy: It has been suggested that HSD17B2 suppresses androgen production by reverse conversion of testosterone or DHT to their upstream precursors, that the expression of HSD17B2 reduces as PCa progresses, and that the overexpression of HSD17B2 suppresses androgen-induced cell proliferation and xenograft growth [9].